UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

BMC cancer, 2023-11, Vol.23 (1), p.1-1090, Article 1090

2023

Volltextzugriff (PDF)

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial

Frontiers in immunology, 2023-08, Vol.14, p.1237916-1237916

2023

Volltextzugriff (PDF)

Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia

Frontiers in immunology, 2022-08, Vol.13, p.921293-921293

2022

Volltextzugriff (PDF)

Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis

Virology journal, 2024-05, Vol.21 (1), p.103-103, Article 103

2024

Volltextzugriff (PDF)

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study

Frontiers in immunology, 2023-04, Vol.14, p.1169666-1169666

2023

Volltextzugriff (PDF)

Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

Frontiers in oncology, 2024-02, Vol.14, p.1339605-1339605

2024

Volltextzugriff (PDF)

Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

Frontiers in oncology, 2024-04, Vol.14, p.1397607-1397607

2024

Volltextzugriff (PDF)

Dose‐dependent effect of megestrol acetate supplementation in cancer patients with anorexia–cachexia syndrome: A meta‐analysis

Journal of cachexia, sarcopenia and muscle, 2024-08, Vol.15 (4), p.1254-1263

2024

Volltextzugriff (PDF)

Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up

Cell transplantation, 2023-01, Vol.32, p.9636897231163212-9636897231163212

2023

Volltextzugriff (PDF)

The effect of oral nutrition supplement (ONS) on the nutritional and clinical status of patients undergoing autologous hematopoietic stem cell transplantation: study protocol for a randomized controlled clinical trial

BMC nutrition, 2024-06, Vol.10 (1), p.1-83, Article 83

2024

Volltextzugriff (PDF)

Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease-19

Case reports in hematology, 2022, Vol.2022, p.2603607-6

2022

Volltextzugriff (PDF)

Comparison of three malnutrition screening tools prior to allogeneic hematopoietic stem-cell transplantation

Frontiers in nutrition (Lausanne), 2023-10, Vol.10, p.1233074-1233074

2023

Volltextzugriff (PDF)

Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience

International journal of hematology- oncology and stem cell research, 2023-07, Vol.17 (3), p.156-166

2023

Volltextzugriff (PDF)

Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial

Vaccines (Basel), 2023-01, Vol.11 (1), p.117

2023

Volltextzugriff (PDF)

Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation

International journal of hematology- oncology and stem cell research, 2021-01, Vol.15 (1), p.51-60

2021

Volltextzugriff (PDF)

Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Coronavirus Disease 2019 (COVID-19) Pandemic: An Iranian Consensus

Mediterranean journal of hematology and infectious diseases, 2020-06, Vol.12 (1), p.e2020050

2020

Volltextzugriff (PDF)

Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial

International journal of hematology- oncology and stem cell research, 2018-04, Vol.12 (2)

2018

Volltextzugriff (PDF)

Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation

Clinical transplantation, 2024-06, Vol.38 (6), p.e15371-n/a

2024

Volltextzugriff (PDF)

Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience

Leukemia research, 2022-09, Vol.120, p.106918-106918, Article 106918

2022

Volltextzugriff (PDF)

The impact of malnutrition on mortality and complications of hematopoietic stem cell transplantation in patients with acute leukemia

Clinical nutrition (Edinburgh, Scotland), 2023-12, Vol.42 (12), p.2520-2527

2023

Volltextzugriff (PDF)

Advances in natural killer cell therapies for breast cancer

Immunology and cell biology, 2023-09, Vol.101 (8), p.705-726

2023

Volltextzugriff (PDF)

Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis

Reviews in medical virology, 2024-07, Vol.34 (4), p.e2558-n/a

2024

Volltextzugriff (PDF)

Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up

Gene reports, 2022-12, Vol.29, p.101691-101691, Article 101691

2022

Volltextzugriff (PDF)

Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the COVID-19 Pandemic: An Iranian Consensus

Mediterranean journal of hematology and infectious diseases, 2020-07, Vol.12 (1), p.e2020050-e2020050

2020

Volltextzugriff (PDF)

SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial

International journal of hematology- oncology and stem cell research, 2018-04, Vol.12 (2), p.77-83

2018

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Englisch
(31)
Persisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Hematopoietic Stem Cell Transplantation
(10)
Clinical Trials
(6)
Immunology
(6)
Humans
(5)
Patients
(5)
Transplantation
(5)
Cancer Therapies
(4)
Cell Therapy
(4)
Chemotherapy
(4)
Covid-19
(4)
Hematology
(4)
Hematopoietic Stem Cells
(4)
Leukemia
(4)
Oncology
(4)
Original
(4)
Stem Cell Transplantation
(4)
Acute Myeloid Leukemia
(3)
Bone Marrow
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial

Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia

Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study

Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

Dose‐dependent effect of megestrol acetate supplementation in cancer patients with anorexia–cachexia syndrome: A meta‐analysis

Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up

The effect of oral nutrition supplement (ONS) on the nutritional and clinical status of patients undergoing autologous hematopoietic stem cell transplantation: study protocol for a randomized controlled clinical trial

Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease-19

Comparison of three malnutrition screening tools prior to allogeneic hematopoietic stem-cell transplantation

Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience

Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial

Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation

Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Coronavirus Disease 2019 (COVID-19) Pandemic: An Iranian Consensus

Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial

Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience

The impact of malnutrition on mortality and complications of hematopoietic stem cell transplantation in patients with acute leukemia

Advances in natural killer cell therapies for breast cancer

Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis

Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up

Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the COVID-19 Pandemic: An Iranian Consensus

SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial

Suchergebnisse filtern